What's on the web on your pursuit, hobbies, interests and worries

GraftVersusHostDisease news

Korean fund to invest in Enlivex Therapeutics at $100m value

גלובס - Apr 23, 2018
Enlivex Therapeutics Ltd., which is developing a treatment for Graft-versus-Host disease (GvHD) resulting from bone-marrow transplants, has announced the signing of a memorandum of understanding (MoU) for a $10 million investment led by South Korean ...

Kalytera receives US patent covering use of CBD to treat severe and refractory graft versus host disease

pharmabiz.com - Apr 23, 2018
Kalytera Therapeutics, Inc., a clinical-stage pharmaceutical company, announced that the US Patent and Trademark Office (USPTO) issued US Patent No. 9,889,100 B2 with claims covering the use of cannabidiol (CBD) for the treatment of severe and ...

Costimulatory Molecule Blockade For The Treatment Of Graft-Versus-Host Disease

Science Trends - Apr 7, 2018
Allogeneic hematopoietic stem cell transplantation (HCT) has been widely used to treat both malignant and nonmalignant hematological disorders. Despite remarkable success, one complication that occurs in up to approximately 50% of patients undergoing ...

Graft Versus Host Disease - premium items on eBay

Atlas of Graft-versus-host Disease: Approaches to Diagnosis and Treatment Hardco


Chronic Graft Versus Host Disease : Interdisciplinary Management (2009,...


Chronic Graft Versus Host Disease: Interdisciplinary Manag (UK I


>> Go to all great Graft Versus Host Disease deals on eBay

Graft Versus Host Disease pictures on the web

>> Show

Graft Versus Host Disease videos

Introduction to Chronic Graft versus Host Disease

2016 Celebrating a Second Chance at Life Survivorship Symposium Workshop: Introduction to Chronic Graft-Versus-Host Disease Speaker: John Galvin MD, MS, MPH, Northwestern Hematopoietic Cell...

Graft-Versus-Host Disease/Graft-Versus-Leukemia: Recent Advances in Therapy


Graft-Versus-Host Disease: Diagnostic and Therapeutic Advances

2013 Clinical Education Conference Daniel R Couriel, MD, University of Michigan.

Akute okkuläre Graft versus host disease


Graft-versus-host disease research shows promise | Dana-Farber Cancer Institute

John Koreth, MBBS, DPhil, discusses the results of a clinical trial to treat patients with graft-versus-host disease (GVHD), which can affect the immune system after transplant. He notes that...